Literature DB >> 7759139

Identification of a novel HLA-A2 subtype, HLA-A*0216.

D Barouch1, P Krausa, J Bodmer, M J Browning, A J McMichael.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7759139     DOI： 10.1007/BF00164000

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  6 in total

1.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  A new HLA-A2 variant (HLA-A2-SLU) identified by one-dimensional isoelectric focusing.

Authors:  M G Guttridge; S G Marsh; P T Klouda
Journal:  Tissue Antigens       Date:  1992-01

3.  DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28.

Authors:  M A Fernandez-Viña; M Falco; Y Sun; P Stastny
Journal:  Hum Immunol       Date:  1992-03       Impact factor: 2.850

4.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

5.  Nomenclature for factors of the HLA system, 1994.

Authors:  J G Bodmer; S G Marsh; E D Albert; W F Bodmer; B Dupont; H A Erlich; B Mach; W R Mayr; P Parham; T Sasazuki
Journal:  Tissue Antigens       Date:  1994-07

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205
  6 in total
  2 in total

Review 1.  Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs.

Authors:  D L Doolan; B Wizel; S L Hoffman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

2.  HLA-A2 subtypes are functionally distinct in peptide binding and presentation.

Authors:  D Barouch; T Friede; S Stevanović; L Tussey; K Smith; S Rowland-Jones; V Braud; A McMichael; H G Rammensee
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.